Dr. Sibel Blau

Dr. Sibel Blau serves as President and Chief Executive Officer of Exigent Research Network, an innovative research network formed from a partnership between the Quality Cancer Care Alliance (QCCA) and the National Cancer Care Alliance (NCCA). She is a Hematologist and Oncologist with special interest and expertise in breast cancer, multiple myeloma, and cell therapy, bringing decades of clinical and research leadership to the role.

Dr. Blau is the President/Executive Chair of the board at Northwest Medical Specialties, PLLC, where she also runs the clinical research and Precision Medicine program. She is one of the founding members and the President/CEO and Co-Chair of ONCare Alliance, LLC, a national organization focused on value-based care, education, and research. She is a board member and the current President of Washington State Medical Oncology Society (WSMOS). Locally, she founded the Journey Fund, a nonprofit supporting patients facing barriers to treatment.

Education and Training

• Medical degree from Istanbul University / Cerrahpasa Medical Faculty (1987)
• Hematology-Oncology Fellowship, Case Western Reserve University, Cleveland, OH
• Stem Cell Transplant Fellowship, Fred Hutchinson Cancer Research Center, Seattle, WA
• Internal Medicine Internship, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio
• Board Certification: Medical Oncology

Career History

• President and CEO, Exigent Research Network
• President/Executive Chair, Northwest Medical Specialties, PLLC
• President/CEO and Co-Chair, ONCare Alliance, LLC
• Chief Innovation Officer, MultiCare Cancer Institute
• Medical Oncologist, Northwest Medical Specialties (clinical practice since 2001)

What Dr. Blau could bring to Exigent Research Network: With her proven track record building and scaling the Quality Cancer Care Alliance into a national organization, along with her clinical expertise in breast cancer and multiple myeloma, Dr. Blau brings deep credibility in community oncology innovation. Her ability to navigate complex healthcare economics, establish value-based care models, and drive clinical research adoption positions her to accelerate Exigent's mission of democratizing access to clinical trials. Her founding of the Journey Fund and her advocacy for independent oncology practices demonstrate her commitment to equitable cancer care—precisely the values that drive Exigent's network-based model.